Ricardo Rojo

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Eric L. Simpson, Rodney Sinclair, Seth Forman et al. · The Lancet · 2020 · 491 citations · Full text

Medicine, Dermatology, Immunology +14

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg et al. · New England Journal of Medicine · 2021 · 453 citations · Full text

Medicine, Dermatology, Pharmacology +15

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis

Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen et al. · JAMA Dermatology · 2020 · 388 citations · Full text

Medicine, Dermatology, Pharmacology +12

Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial

Kristian Reich, Jacob P. Thyssen, Andrew Blauvelt et al. · The Lancet · 2022 · 237 citations

Life Sciences, Dermatology, Immunology +12

Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis

Lawrence F. Eichenfield, Carsten Flohr, Robert Sidbury et al. · JAMA Dermatology · 2021 · 162 citations · Full text

Medicine, Dermatology, Pharmacotherapy +16